Evidence map›Paper›PMID 31850920›Full record

ReviewCurrent opinion in allergy and clinical immunology2020

Prevention of baker's asthma.

Mohamed F Jeebhay, Roslynn Baatjies

Abstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Occupational Respiratory Allergy to Flour in the Modern Era.Current allergy and asthma reports · 2025
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohamed F JeebhayOccupational Medicine Division and Centre for Environmental and Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town.
Roslynn BaatjiesOccupational Medicine Division and Centre for Environmental and Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town.

Funding

RESEARCH TRAINING IN SOUTH AFRICAD43TW000812 · FIC · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBINS, THOMAS G · 1996 to 2011
$2.6M
Research Training on Chronic Lung Diseases in Southern AfricaD43ES018744 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI IRUSEN, ELVISEGRAN MALCOLM, JEEBHAY, MOHAMED FAREED · 2009 to 2013
$1.1M
FIC NIH HHS D43 TW000812NIEHS NIH HHS D43 ES018744
6 · The paper itself

Abstract

purpose of reviewBaker's allergy and asthma continue to represent an important contributor of occupational asthma globally. This review identified recent studies related to the prevention of baker's allergy and asthma. RECENT

findingsStudies with respect to regulatory exposure standards, workplace control measures aimed at reduction of flour dust exposures, surveillance programmes (exposure monitoring, medical surveillance) and workplace information, education and training programmes were identified. SUMMARY: Detailed knowledge on risk factors and detection methods to assess exposure and early identification of high-risk workers exist, but workplace control measures remain sub-optimal because they are rarely multifaceted. This is compounded by the lack of health-based exposure standards globally. Exposure level monitoring and medical surveillance are integral to assessing effectiveness of preventive strategies. Triage systems for optimizing the efficiency of medical surveillance programmes show promise, but need replication in different contexts. Future studies need to focus on evaluating the relevance and quantification of peak exposures in increasing risk; developing standardized respiratory questionnaires for medical surveillance; and further exploration of serial fractional exhaled nitric oxide (FeNO) measurements as an adjunct to allergic sensitization for the early identification of baker's asthma and assessing the long-term impact of interventions.

Indexed as

AllergensAlveolitis, Extrinsic AllergicAsthma, OccupationalBreath TestsDustEnvironmental MonitoringFlourHumansInhalation ExposureOccupational ExposureWorkplaceAllergensDust

Identifiers

PMID31850920
PMCPMC7326308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.